Standout Papers

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC... 2014 2026 2018 2022 301
  1. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry (2014)
    Jan Beyer‐Westendorf, Sven Pannach et al. Blood

Immediate Impact

61 standout
Sub-graph 1 of 23

Citing Papers

Stroke
2024 Standout
Acute Pulmonary Embolism
2022 Standout
2 intermediate papers

Works of Kurtuluş Şahin being referenced

Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial
2017
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
2014 Standout

Author Peers

Author Last Decade Papers Cites
Kurtuluş Şahin 795 568 76 145 31 1.1k
Elisa Grifoni 512 372 29 97 42 860
J.F. Martin 551 516 31 251 32 1.3k
Mandy N. Lauw 412 320 69 58 36 878
Erica Romualdi 449 451 65 222 32 1.0k
Nilima A. Patwardhan 350 539 26 353 25 1.2k
Nelly G. Adel 189 219 111 146 26 1.4k
Franca Bilora 423 410 67 206 42 1.2k
Manu Varma 353 468 22 401 19 970
Helen Varker 716 205 44 91 35 972
Nick R. Bijsterveld 504 437 45 273 29 937

All Works

Loading papers...

Rankless by CCL
2026